GAO Studies PBM-Obtained Rebates

18 August 1996

In 1995, pharmacy benefit managers used in US states operating the Federal Employees Health Benefits Program obtained manufacturer discounts of $107 million, or 21.2% of total pharmacy savings made for the Program by the PBMs, the General Accounting Office reports. The FEHBP uses Medco for mail-order pharmacy and PCS for retail business.

$264 million, or 52.3% of the savings, came from retail and mail-order pharmacy, with $72 million saved from maximum allowable cost pricing for generics and about $10 million from concurrent and retrospective drug utilization review.

The GAO says the new 20% retail-only co-payment produced a major shift to mail-order. In the first five months of 1996, the total amount paid to retail pharmacies by PCS for prescriptions dispensed to Program members affected by the co-payment fell about $95 million, or 36%, against the like, year-earlier period.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight